CompanyDrug

Hengrui Medicine’s SHR-A1811 Combo Receives NMPA Approval for HER2+ NSCLC Study

CompanyDeals

Ascentage Pharma Launches Olverembatinib Named Patient Program with Tanner Pharma

Drug

Sirnaomics’ STP705 Receives Approval for Liver Cancer Trial in Taiwan

CompanyDrug

GenFleet Therapeutics’ GFH018 Receives CTA Approval for Two Clinical Trials in China

CompanyDeals

NMPA Approves Genuine Biotech’s Azvudine for COVID-19, Fosun Pharma Inks Licensing Deal

Policy / Regulatory

Chinese Pharmacists Association Releases Draft VBP Drug Management Guidelines for Public Feedback

CompanyDeals

3D Medicines Files IPO Prospectus for Hong Kong Listing

CompanyDrug

I-Mab Doses First Patient in Global Phase I Study for TJ-CD4B in Solid Tumors

CompanyDeals

Rona Therapeutics Licenses Sanofi’s siRNA Platform for Global Development

CompanyDigital

ApolloBio Corp. Initiates Pre-Clinical Study for ABC-5100 Nanobody Against COVID-19

CompanyDeals

InventisBio Raises USD 308M in Shanghai STAR IPO, Valued at USD 1.54B

Policy / Regulatory

NMPA Releases 56th Batch of GQCE Reference Drugs, Including 14 Injectables